{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T01:01:07Z","timestamp":1790816467496,"version":"4.1.0"},"reference-count":129,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T00:00:00Z","timestamp":1783382400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"vor","delay-in-days":86,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100006769","name":"Russian Science Foundation","doi-asserted-by":"publisher","award":["23-74-10092"],"award-info":[{"award-number":["23-74-10092"]}],"id":[{"id":"10.13039\/501100006769","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Discov."],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Accumulation of amyloid fibrils is a key factor in the pathogenesis of progressive diseases, including neurodegenerative disorders such as Alzheimer\u2019s and Parkinson\u2019s disease, as well as systemic amyloidosis. Although amyloid deposits are known to persist in vivo for years or even decades, it remains unclear how the structure and biological properties of mature fibrils evolve during prolonged post-assembly residence. Here, we addressed this question using a simplified cell-free aqueous model designed to isolate the intrinsic time-dependent behavior of mature amyloid aggregates from the complexity of the biological milieu. Specifically, we investigated the long-term evolution of two polymorphs of lysozyme amyloid fibrils as model systems with distinct clustering propensities that mimic the diversity of amyloid deposits. We challenge the assumption of amyloid stability by demonstrating their spontaneous degradation over 16 months at physiological temperature, a process we define as amyloid \u201caging\u201d. This process is characterized by aggregate declustering, fibril shortening, and progressive depolymerization into monomeric subunits, accompanied by a pronounced reduction in intrinsic toxicity across multiple human cell lines. Notably, \u201caged\u201d fibrils were disassembled and degraded more efficiently than freshly prepared aggregates by the molecular chaperone \u03b1-B-crystallin and immune-associated proteases, including matrix metalloproteinase-9 and cathepsins B and D. However, this enhanced degradation revealed a paradox: accelerated processing of \u201caged\u201d amyloids did not always reduce cytotoxicity and, in some cases, even exacerbated it, consistent with the generation of biologically active fibril-derived species rather than their complete conversion into non-toxic monomers. We provide the first systematic evidence that mature amyloids are dynamic structures undergoing spontaneous degradation that fundamentally alters their cytotoxicity and susceptibility to biological clearance. Our results introduce amyloid aging as a previously underappreciated dimension of amyloid biology and emphasize the need to account for fibril \u201cage\u201d when evaluating pathogenic potential and developing anti-amyloid therapeutic strategies.<\/jats:p>","DOI":"10.1038\/s41420-026-03245-1","type":"journal-article","created":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T16:24:50Z","timestamp":1783441490000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Spontaneous aging of mature amyloids alters structural stability, cytotoxicity, and susceptibility to biological clearance"],"prefix":"10.1038","volume":"12","author":[{"given":"Maksim I.","family":"Sulatsky","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olga V.","family":"Stepanenko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arina A.","family":"Kayda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3779-6711","authenticated-orcid":false,"given":"Olesya V.","family":"Stepanenko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ekaterina V.","family":"Mikhailova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1207-3384","authenticated-orcid":false,"given":"Anna I.","family":"Sulatskaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,7]]},"reference":[{"key":"3245_CR1","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1038\/s41580-018-0060-8","volume":"19","author":"MG Iadanza","year":"2018","unstructured":"Iadanza MG, Jackson MP, Hewitt EW, Ranson NA, Radford SE. A new era for understanding amyloid structures and disease. Nat Rev Mol Cell Biol. 2018;19:755\u201373.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"3245_CR2","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1146\/annurev-biochem-061516-045115","volume":"86","author":"F Chiti","year":"2017","unstructured":"Chiti F, Dobson CM. Protein misfolding, amyloid formation, and human disease: a summary of progress over the last decade. Annu Rev Biochem. 2017;86:27\u201368.","journal-title":"Annu Rev Biochem"},{"key":"3245_CR3","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1080\/13506129.2024.2405948","volume":"31","author":"JN Buxbaum","year":"2024","unstructured":"Buxbaum JN, Eisenberg DS, Fandrich M, McPhail ED, Merlini G, Saraiva MJM, et al. Amyloid nomenclature 2024: update, novel proteins, and recommendations by the International Society of Amyloidosis (ISA) Nomenclature Committee. Amyloid. 2024;31:249\u201356.","journal-title":"Amyloid"},{"key":"3245_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuint.2024.105880","volume":"180","author":"J Wu","year":"2024","unstructured":"Wu J, Wu J, Chen T, Cai J, Ren R. Protein aggregation and its affecting mechanisms in neurodegenerative diseases. Neurochem Int. 2024;180:105880.","journal-title":"Neurochem Int"},{"key":"3245_CR5","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1038\/nrm2101","volume":"8","author":"C Haass","year":"2007","unstructured":"Haass C, Selkoe DJ. Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer\u2019s amyloid beta-peptide. Nat Rev Mol Cell Biol. 2007;8:101\u201312.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"3245_CR6","doi-asserted-by":"publisher","first-page":"138","DOI":"10.4103\/0972-2327.144284","volume":"18","author":"M Verma","year":"2015","unstructured":"Verma M, Vats A, Taneja V. Toxic species in amyloid disorders: oligomers or mature fibrils. Ann Indian Acad Neurol. 2015;18:138\u201345.","journal-title":"Ann Indian Acad Neurol"},{"key":"3245_CR7","doi-asserted-by":"publisher","DOI":"10.1002\/chem.202400277","volume":"30","author":"Z Niu","year":"2024","unstructured":"Niu Z, Gui X, Feng S, Reif B. Aggregation mechanisms and molecular structures of amyloid-beta in Alzheimer\u2019s disease. Chemistry. 2024;30:e202400277.","journal-title":"Chemistry"},{"key":"3245_CR8","doi-asserted-by":"publisher","DOI":"10.1002\/agt2.70078","volume":"6","author":"MI Sulatsky","year":"2025","unstructured":"Sulatsky MI, Stepanenko OV, Stepanenko OV, Sulatskaya AI. Solving the amyloid paradox: unveiling the complex pathogenicity of amyloid fibrils. Aggregate. 2025;6:e70078.","journal-title":"Aggregate"},{"key":"3245_CR9","doi-asserted-by":"publisher","DOI":"10.1002\/bies.202200086","volume":"44","author":"A Bigi","year":"2022","unstructured":"Bigi A, Cascella R, Chiti F, Cecchi C. Amyloid fibrils act as a reservoir of soluble oligomers, the main culprits in protein deposition diseases. Bioessays. 2022;44:e2200086.","journal-title":"Bioessays"},{"key":"3245_CR10","doi-asserted-by":"publisher","first-page":"9758","DOI":"10.1073\/pnas.1218402110","volume":"110","author":"SI Cohen","year":"2013","unstructured":"Cohen SI, Linse S, Luheshi LM, Hellstrand E, White DA, Rajah L, et al. Proliferation of amyloid-beta42 aggregates occurs through a secondary nucleation mechanism. Proc Natl Acad Sci USA. 2013;110:9758\u201363.","journal-title":"Proc Natl Acad Sci USA"},{"key":"3245_CR11","doi-asserted-by":"publisher","first-page":"5691","DOI":"10.1073\/pnas.1423174112","volume":"112","author":"KW Tipping","year":"2015","unstructured":"Tipping KW, Karamanos TK, Jakhria T, Iadanza MG, Goodchild SC, Tuma R, et al. pH-induced molecular shedding drives the formation of amyloid fibril-derived oligomers. Proc Natl Acad Sci USA. 2015;112:5691\u20136.","journal-title":"Proc Natl Acad Sci USA"},{"key":"3245_CR12","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1038\/nature03680","volume":"435","author":"R Nelson","year":"2005","unstructured":"Nelson R, Sawaya MR, Balbirnie M, Madsen AO, Riekel C, Grothe R, et al. Structure of the cross-beta spine of amyloid-like fibrils. Nature. 2005;435:773\u20138.","journal-title":"Nature"},{"key":"3245_CR13","doi-asserted-by":"crossref","unstructured":"Chatani E, Yuzu K, Ohhashi Y, Goto Y. Current understanding of the structure, stability and dynamic properties of amyloid fibrils. Int J Mol Sci. 2021;22:4349.","DOI":"10.3390\/ijms22094349"},{"key":"3245_CR14","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1038\/nature05695","volume":"447","author":"MR Sawaya","year":"2007","unstructured":"Sawaya MR, Sambashivan S, Nelson R, Ivanova MI, Sievers SA, Apostol MI, et al. Atomic structures of amyloid cross-beta spines reveal varied steric zippers. Nature. 2007;447:453\u20137.","journal-title":"Nature"},{"key":"3245_CR15","doi-asserted-by":"publisher","first-page":"15806","DOI":"10.1073\/pnas.0604035103","volume":"103","author":"JF Smith","year":"2006","unstructured":"Smith JF, Knowles TP, Dobson CM, Macphee CE, Welland ME. Characterization of the nanoscale properties of individual amyloid fibrils. Proc Natl Acad Sci USA. 2006;103:15806\u201311.","journal-title":"Proc Natl Acad Sci USA"},{"key":"3245_CR16","doi-asserted-by":"publisher","first-page":"5468","DOI":"10.1073\/pnas.1219476110","volume":"110","author":"AW Fitzpatrick","year":"2013","unstructured":"Fitzpatrick AW, Debelouchina GT, Bayro MJ, Clare DK, Caporini MA, Bajaj VS, et al. Atomic structure and hierarchical assembly of a cross-beta amyloid fibril. Proc Natl Acad Sci USA. 2013;110:5468\u201373.","journal-title":"Proc Natl Acad Sci USA"},{"key":"3245_CR17","doi-asserted-by":"publisher","first-page":"1900","DOI":"10.1126\/science.1150057","volume":"318","author":"TP Knowles","year":"2007","unstructured":"Knowles TP, Fitzpatrick AW, Meehan S, Mott HR, Vendruscolo M, Dobson CM, et al. Role of intermolecular forces in defining material properties of protein nanofibrils. Science. 2007;318:1900\u20133.","journal-title":"Science"},{"key":"3245_CR18","doi-asserted-by":"publisher","first-page":"10177","DOI":"10.1039\/D1SC06782F","volume":"13","author":"AK Buell","year":"2022","unstructured":"Buell AK. Stability matters, too - the thermodynamics of amyloid fibril formation. Chem Sci. 2022;13:10177\u201392.","journal-title":"Chem Sci"},{"key":"3245_CR19","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.jare.2024.04.018","volume":"70","author":"MI Sulatsky","year":"2025","unstructured":"Sulatsky MI, Stepanenko OV, Stepanenko OV, Povarova OI, Kuznetsova IM, Turoverov KK, et al. Broken but not beaten: challenge of reducing the amyloids pathogenicity by degradation. J Adv Res. 2025;70:45\u201362.","journal-title":"J Adv Res"},{"key":"3245_CR20","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1007\/s10741-014-9464-5","volume":"20","author":"M Grogan","year":"2015","unstructured":"Grogan M, Dispenzieri A. Natural history and therapy of AL cardiac amyloidosis. Heart Fail Rev. 2015;20:155\u201362.","journal-title":"Heart Fail Rev"},{"key":"3245_CR21","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1111\/j.1365-2141.2007.06936.x","volume":"140","author":"AD Wechalekar","year":"2008","unstructured":"Wechalekar AD, Hawkins PN, Gillmore JD. Perspectives in treatment of AL amyloidosis. Br J Haematol. 2008;140:365\u201377.","journal-title":"Br J Haematol"},{"key":"3245_CR22","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1161\/CIRCULATIONAHA.115.018852","volume":"133","author":"LH Connors","year":"2016","unstructured":"Connors LH, Sam F, Skinner M, Salinaro F, Sun F, Ruberg FL, et al. Heart failure resulting from age-related cardiac amyloid disease associated with wild-type transthyretin: a prospective, observational cohort study. Circulation. 2016;133:282\u201390.","journal-title":"Circulation"},{"key":"3245_CR23","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1038\/s41582-018-0116-6","volume":"15","author":"F Panza","year":"2019","unstructured":"Panza F, Lozupone M, Logroscino G, Imbimbo BP. A critical appraisal of amyloid-beta-targeting therapies for Alzheimer disease. Nat Rev Neurol. 2019;15:73\u201388.","journal-title":"Nat Rev Neurol"},{"key":"3245_CR24","doi-asserted-by":"publisher","first-page":"e1347","DOI":"10.1212\/WNL.0000000000011524","volume":"96","author":"WJ Jagust","year":"2021","unstructured":"Jagust WJ, Landau SM. Alzheimer\u2019s Disease Neuroimaging Initiative. Temporal dynamics of beta-amyloid accumulation in aging and Alzheimer disease. Neurology. 2021;96:e1347\u2013e1357.","journal-title":"Neurology"},{"key":"3245_CR25","doi-asserted-by":"publisher","first-page":"5798","DOI":"10.1016\/j.cell.2023.11.025","volume":"186","author":"M Wilkinson","year":"2023","unstructured":"Wilkinson M, Xu Y, Thacker D, Taylor AIP, Fisher DG, Gallardo RU, et al. Structural evolution of fibril polymorphs during amyloid assembly. Cell. 2023;186:5798\u2013811 e5726.","journal-title":"Cell"},{"key":"3245_CR26","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-44820-3","volume":"15","author":"BA Nguyen","year":"2024","unstructured":"Nguyen BA, Singh V, Afrin S, Yakubovska A, Wang L, Ahmed Y, et al. Structural polymorphism of amyloid fibrils in ATTR amyloidosis revealed by cryo-electron microscopy. Nat Commun. 2024;15:581.","journal-title":"Nat Commun"},{"key":"3245_CR27","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1007\/s13311-023-01405-0","volume":"20","author":"G Yadollahikhales","year":"2023","unstructured":"Yadollahikhales G, Rojas JC. Anti-amyloid immunotherapies for Alzheimer\u2019s disease: a 2023 clinical update. Neurotherapeutics. 2023;20:914\u201331.","journal-title":"Neurotherapeutics"},{"key":"3245_CR28","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1007\/s13139-024-00848-3","volume":"58","author":"KW Park","year":"2024","unstructured":"Park KW. Anti-amyloid antibody therapies for Alzheimer\u2019s disease. Nucl Med Mol Imaging. 2024;58:227\u201336.","journal-title":"Nucl Med Mol Imaging"},{"key":"3245_CR29","doi-asserted-by":"publisher","DOI":"10.1155\/2024\/2052142","volume":"2024","author":"SA Beshir","year":"2024","unstructured":"Beshir SA, Hussain N, Menon VB, Al Haddad AHI, Al Zeer RAK, Elnour AA. Advancements and challenges in antiamyloid therapy for Alzheimer\u2019s disease: a comprehensive review. Int J Alzheimers Dis. 2024;2024:2052142.","journal-title":"Int J Alzheimers Dis"},{"key":"3245_CR30","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-54091-7","volume":"15","author":"S Karimi-Farsijani","year":"2024","unstructured":"Karimi-Farsijani S, Sharma K, Ugrina M, Kuhn L, Pfeiffer PB, Haupt C, et al. Cryo-EM structure of a lysozyme-derived amyloid fibril from hereditary amyloidosis. Nat Commun. 2024;15:9648.","journal-title":"Nat Commun"},{"key":"3245_CR31","first-page":"42","volume":"3","author":"C Pleyer","year":"2015","unstructured":"Pleyer C, Flesche J, Saeed F. Lysozyme amyloidosis - a case report and review of the literature. Clin Nephrol Case Stud. 2015;3:42\u201345.","journal-title":"Clin Nephrol Case Stud"},{"key":"3245_CR32","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/B978-0-12-386483-3.00003-3","volume":"84","author":"R Swaminathan","year":"2011","unstructured":"Swaminathan R, Ravi VK, Kumar S, Kumar MV, Chandra N. Lysozyme: a model protein for amyloid research. Adv Protein Chem Struct Biol. 2011;84:63\u2013111.","journal-title":"Adv Protein Chem Struct Biol"},{"key":"3245_CR33","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2021.812096","volume":"8","author":"T Matsuo","year":"2021","unstructured":"Matsuo T, De Francesco A, Peters J. Molecular dynamics of lysozyme amyloid polymorphs studied by incoherent neutron scattering. Front Mol Biosci. 2021;8:812096.","journal-title":"Front Mol Biosci"},{"key":"3245_CR34","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1016\/j.jmb.2010.07.005","volume":"402","author":"MF Mossuto","year":"2010","unstructured":"Mossuto MF, Dhulesia A, Devlin G, Frare E, Kumita JR, de Laureto PP, et al. The non-core regions of human lysozyme amyloid fibrils influence cytotoxicity. J Mol Biol. 2010;402:783\u201396.","journal-title":"J Mol Biol"},{"key":"3245_CR35","doi-asserted-by":"crossref","unstructured":"Mikalauskaite K, Ziaunys M, Smirnovas V. Lysozyme amyloid fibril structural variability dependence on initial protein folding state. Int J Mol Sci. 2022;23(16):9474.","DOI":"10.3390\/ijms23105421"},{"key":"3245_CR36","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.jsb.2004.08.002","volume":"149","author":"MR Krebs","year":"2005","unstructured":"Krebs MR, Bromley EH, Donald AM. The binding of thioflavin-T to amyloid fibrils: localisation and implications. J Struct Biol. 2005;149:30\u201337.","journal-title":"J Struct Biol"},{"key":"3245_CR37","doi-asserted-by":"publisher","first-page":"e15385","DOI":"10.1371\/journal.pone.0015385","volume":"5","author":"AI Sulatskaya","year":"2010","unstructured":"Sulatskaya AI, Maskevich AA, Kuznetsova IM, Uversky VN, Turoverov KK. Fluorescence quantum yield of thioflavin T in rigid isotropic solution and incorporated into the amyloid fibrils. PLoS One. 2010;5:e15385.","journal-title":"PLoS One"},{"key":"3245_CR38","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.molstruc.2016.10.037","volume":"1140","author":"AI Sulatskaya","year":"2017","unstructured":"Sulatskaya AI, Rodina NP, Povarova OI, Kuznetsova IM, Turoverov KK. Different conditions of fibrillogenesis cause polymorphism of lysozyme amyloid fibrils. J Mol Struct. 2017;1140:52\u201358.","journal-title":"J Mol Struct"},{"key":"3245_CR39","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.bpj.2011.10.041","volume":"102","author":"BR Shah","year":"2012","unstructured":"Shah BR, Maeno A, Matsuo H, Tachibana H, Akasaka K. Pressure-accelerated dissociation of amyloid fibrils in wild-type hen lysozyme. Biophys J. 2012;102:121\u20136.","journal-title":"Biophys J"},{"key":"3245_CR40","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1016\/j.bbapap.2017.07.017","volume":"1865","author":"S Sonavane","year":"2017","unstructured":"Sonavane S, Haider SZ, Kumar A, Ahmad B. Hemin is able to disaggregate lysozyme amyloid fibrils into monomers. Biochim Biophys Acta Proteins Proteom. 2017;1865:1315\u201325.","journal-title":"Biochim Biophys Acta Proteins Proteom"},{"key":"3245_CR41","doi-asserted-by":"publisher","first-page":"2857","DOI":"10.2147\/IJN.S132472","volume":"12","author":"YC Kuo","year":"2017","unstructured":"Kuo YC, Tsao CW. Neuroprotection against apoptosis of SK-N-MC cells using RMP-7- and lactoferrin-grafted liposomes carrying quercetin. Int J Nanomed. 2017;12:2857\u201369.","journal-title":"Int J Nanomed"},{"key":"3245_CR42","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.cbi.2015.07.013","volume":"240","author":"CL Lin","year":"2015","unstructured":"Lin CL, Huang WN, Li HH, Huang CN, Hsieh S, Lai C, et al. Hydrogen-rich water attenuates amyloid beta-induced cytotoxicity through upregulation of Sirt1-FoxO3a by stimulation of AMP-activated protein kinase in SK-N-MC cells. Chem Biol Interact. 2015;240:12\u201321.","journal-title":"Chem Biol Interact"},{"key":"3245_CR43","doi-asserted-by":"publisher","first-page":"5954","DOI":"10.1016\/j.biomaterials.2014.03.082","volume":"35","author":"YC Kuo","year":"2014","unstructured":"Kuo YC, Wang CT. Protection of SK-N-MC cells against beta-amyloid peptide-induced degeneration using neuron growth factor-loaded liposomes with surface lactoferrin. Biomaterials. 2014;35:5954\u201364.","journal-title":"Biomaterials"},{"key":"3245_CR44","doi-asserted-by":"publisher","first-page":"1580","DOI":"10.1046\/j.1471-4159.1997.69041580.x","volume":"69","author":"HW Querfurth","year":"1997","unstructured":"Querfurth HW, Jiang J, Geiger JD, Selkoe DJ. Caffeine stimulates amyloid beta-peptide release from beta-amyloid precursor protein-transfected HEK293 cells. J Neurochem. 1997;69:1580\u201391.","journal-title":"J Neurochem"},{"key":"3245_CR45","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1042\/bj3340079","volume":"334","author":"HW Querfurth","year":"1998","unstructured":"Querfurth HW, Haughey NJ, Greenway SC, Yacono PW, Golan DE, Geiger JD. Expression of ryanodine receptors in human embryonic kidney (HEK293) cells. Biochem J. 1998;334:79\u201386.","journal-title":"Biochem J"},{"key":"3245_CR46","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1016\/j.neuint.2007.03.001","volume":"50","author":"A Domingues","year":"2007","unstructured":"Domingues A, Almeida S, da Cruz e Silva EF, Oliveira CR, Rego AC. Toxicity of beta-amyloid in HEK293 cells expressing NR1\/NR2A or NR1\/NR2B N-methyl-D-aspartate receptor subunits. Neurochem Int. 2007;50:872\u201380.","journal-title":"Neurochem Int"},{"key":"3245_CR47","doi-asserted-by":"publisher","first-page":"4382","DOI":"10.1039\/D3RA07869H","volume":"14","author":"S Samui","year":"2024","unstructured":"Samui S, Biswas S, Basak S, Ghosh S, Muniyappa K, Naskar J. De novo designed aliphatic and aromatic peptides assemble into amyloid-like cytotoxic supramolecular nanofibrils. RSC Adv. 2024;14:4382\u20138.","journal-title":"RSC Adv"},{"key":"3245_CR48","doi-asserted-by":"publisher","first-page":"e36377","DOI":"10.1371\/journal.pone.0036377","volume":"7","author":"M Zhu","year":"2012","unstructured":"Zhu M, Li W, Lu C. Role of alpha-synuclein protein levels in mitochondrial morphology and cell survival in cell lines. PLoS ONE. 2012;7:e36377.","journal-title":"PLoS ONE"},{"key":"3245_CR49","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/2047-9158-2-20","volume":"2","author":"N Braidy","year":"2013","unstructured":"Braidy N, Gai WP, Xu YH, Sachdev P, Guillemin GJ, Jiang XM, et al. Uptake and mitochondrial dysfunction of alpha-synuclein in human astrocytes, cortical neurons and fibroblasts. Transl Neurodegener. 2013;2:20.","journal-title":"Transl Neurodegener"},{"key":"3245_CR50","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1038\/labinvest.2013.83","volume":"93","author":"Y Misumi","year":"2013","unstructured":"Misumi Y, Ando Y, Goncalves NP, Saraiva MJ. Fibroblasts endocytose and degrade transthyretin aggregates in transthyretin-related amyloidosis. Lab Invest. 2013;93:911\u201320.","journal-title":"Lab Invest"},{"key":"3245_CR51","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1038\/s41420-025-02343-w","volume":"11","author":"MI Sulatsky","year":"2025","unstructured":"Sulatsky MI, Stepanenko OV, Stepanenko OV, Mikhailova EV, Sulatskaya AI. Cathepsin B prevents cell death by fragmentation and destruction of pathological amyloid fibrils. Cell Death Discov. 2025;11:61.","journal-title":"Cell Death Discov"},{"key":"3245_CR52","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2024.136362","volume":"281","author":"OV Stepanenko","year":"2024","unstructured":"Stepanenko OV, Sulatsky MI, Mikhailova EV, Stepanenko OV, Sulatskaya AI. Degradation of pathogenic amyloids induced by matrix metalloproteinase-9. Int J Biol Macromol. 2024;281:136362.","journal-title":"Int J Biol Macromol"},{"key":"3245_CR53","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2025.140971","volume":"304","author":"MI Sulatsky","year":"2025","unstructured":"Sulatsky MI, Stepanenko OV, Stepanenko OV, Mikhailova EV, Sulatskaya AI. From protective enzyme to facilitator of amyloid propagation: cathepsin D-mediated amyloid fibril fragmentation. Int J Biol Macromol. 2025;304:140971.","journal-title":"Int J Biol Macromol"},{"key":"3245_CR54","doi-asserted-by":"crossref","unstructured":"Stepanenko OV, Sulatsky MI, Mikhailova EV, Stepanenko OV, Povarova OI, Kuznetsova IM, et al. Alpha-B-crystallin effect on mature amyloid fibrils: different degradation mechanisms and changes in cytotoxicity. Int J Mol Sci. 2020;21:7652.","DOI":"10.3390\/ijms21207659"},{"key":"3245_CR55","doi-asserted-by":"crossref","unstructured":"Sulatsky MI, Stepanenko OV, Stepanenko OV, Sulatskaya AI. Amyloid degradation mechanisms and potential synergistic effects. Neural Regen Res. 2026;21:1981\u20132.","DOI":"10.4103\/NRR.NRR-D-24-01534"},{"key":"3245_CR56","doi-asserted-by":"publisher","first-page":"2811","DOI":"10.1016\/j.bpj.2013.10.034","volume":"105","author":"WF Xue","year":"2013","unstructured":"Xue WF, Radford SE. An imaging and systems modeling approach to fibril breakage enables prediction of amyloid behavior. Biophys J. 2013;105:2811\u20139.","journal-title":"Biophys J"},{"key":"3245_CR57","doi-asserted-by":"publisher","first-page":"3367","DOI":"10.1016\/j.biomaterials.2010.11.066","volume":"32","author":"R Paparcone","year":"2011","unstructured":"Paparcone R, Buehler MJ. Failure of Abeta(1-40) amyloid fibrils under tensile loading. Biomaterials. 2011;32:3367\u201374.","journal-title":"Biomaterials"},{"key":"3245_CR58","doi-asserted-by":"publisher","first-page":"3380","DOI":"10.1073\/pnas.1502214112","volume":"112","author":"AW Fitzpatrick","year":"2015","unstructured":"Fitzpatrick AW, Vanacore GM, Zewail AH. Nanomechanics and intermolecular forces of amyloid revealed by four-dimensional electron microscopy. Proc Natl Acad Sci USA. 2015;112:3380\u20135.","journal-title":"Proc Natl Acad Sci USA"},{"key":"3245_CR59","doi-asserted-by":"crossref","unstructured":"Brudar S, Hribar-Lee B. The role of buffers in wild-type HEWL amyloid fibril formation mechanism. Biomolecules 2019;9:65.","DOI":"10.3390\/biom9020065"},{"key":"3245_CR60","doi-asserted-by":"crossref","unstructured":"Lovestam S, Koh FA, van Knippenberg B, Kotecha A, Murzin AG, Goedert M, et al. Assembly of recombinant tau into filaments identical to those of Alzheimer\u2019s disease and chronic traumatic encephalopathy. eLife. 2022;11:e76494.","DOI":"10.7554\/eLife.76494"},{"key":"3245_CR61","doi-asserted-by":"publisher","first-page":"8478","DOI":"10.1021\/bi300574r","volume":"51","author":"PJ Marek","year":"2012","unstructured":"Marek PJ, Patsalo V, Green DF, Raleigh DP. Ionic strength effects on amyloid formation by amylin are a complicated interplay among Debye screening, ion selectivity, and Hofmeister effects. Biochemistry. 2012;51:8478\u201390.","journal-title":"Biochemistry"},{"key":"3245_CR62","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1111\/j.1749-6632.2001.tb05632.x","volume":"928","author":"ER Stadtman","year":"2001","unstructured":"Stadtman ER. Protein oxidation in aging and age-related diseases. Ann N Y Acad Sci. 2001;928:22\u201338.","journal-title":"Ann N Y Acad Sci"},{"key":"3245_CR63","doi-asserted-by":"publisher","first-page":"3107","DOI":"10.1167\/iovs.09-4308","volume":"51","author":"PG Hains","year":"2010","unstructured":"Hains PG, Truscott RJ. Age-dependent deamidation of lifelong proteins in the human lens. Invest Ophthalmol Vis Sci. 2010;51:3107\u201314.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"3245_CR64","doi-asserted-by":"publisher","first-page":"1590","DOI":"10.1248\/bpb.28.1590","volume":"28","author":"T Shimizu","year":"2005","unstructured":"Shimizu T, Matsuoka Y, Shirasawa T. Biological significance of isoaspartate and its repair system. Biol Pharm Bull. 2005;28:1590\u20136.","journal-title":"Biol Pharm Bull"},{"key":"3245_CR65","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s40478-017-0505-x","volume":"6","author":"ML Moro","year":"2018","unstructured":"Moro ML, Phillips AS, Gaimster K, Paul C, Mudher A, Nicoll JAR, et al. Pyroglutamate and Isoaspartate modified Amyloid-Beta in ageing and Alzheimer\u2019s disease. Acta Neuropathol Commun. 2018;6:3.","journal-title":"Acta Neuropathol Commun"},{"key":"3245_CR66","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1016\/j.redox.2017.10.014","volume":"14","author":"C Cheignon","year":"2018","unstructured":"Cheignon C, Tomas M, Bonnefont-Rousselot D, Faller P, Hureau C, Collin F. Oxidative stress and the amyloid beta peptide in Alzheimer\u2019s disease. Redox Biol. 2018;14:450\u201364.","journal-title":"Redox Biol"},{"key":"3245_CR67","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.34067\/KID.0004922020","volume":"1","author":"I Portales-Castillo","year":"2020","unstructured":"Portales-Castillo I, Yee J, Tanaka H, Fenves AZ. Beta-2 microglobulin amyloidosis: past, present, and future. Kidney360. 2020;1:1447\u201355.","journal-title":"Kidney360"},{"key":"3245_CR68","doi-asserted-by":"crossref","unstructured":"Sulatskaya AI, Rodina NP, Polyakov DS, Sulatsky MI, Artamonova TO, Khodorkovskii MA, et al. Structural features of amyloid fibrils formed from the full-length and truncated forms of beta-2-microglobulin probed by fluorescent dye thioflavin T. Int J Mol Sci. 2018;19:2769.","DOI":"10.3390\/ijms19092762"},{"key":"3245_CR69","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-36791-8","volume":"14","author":"M Wilkinson","year":"2023","unstructured":"Wilkinson M, Gallardo RU, Martinez RM, Guthertz N, So M, Aubrey LD, et al. Disease-relevant beta(2)-microglobulin variants share a common amyloid fold. Nat Commun. 2023;14:1190.","journal-title":"Nat Commun"},{"key":"3245_CR70","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-06761-6","volume":"9","author":"MG Iadanza","year":"2018","unstructured":"Iadanza MG, Silvers R, Boardman J, Smith HI, Karamanos TK, Debelouchina GT, et al. The structure of a beta(2)-microglobulin fibril suggests a molecular basis for its amyloid polymorphism. Nat Commun. 2018;9:4517.","journal-title":"Nat Commun"},{"key":"3245_CR71","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s13311-014-0313-y","volume":"12","author":"GK Gouras","year":"2015","unstructured":"Gouras GK, Olsson TT, Hansson O. beta-Amyloid peptides and amyloid plaques in Alzheimer\u2019s disease. Neurotherapeutics. 2015;12:3\u201311.","journal-title":"Neurotherapeutics"},{"key":"3245_CR72","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1016\/j.jmb.2008.11.005","volume":"386","author":"J Meinhardt","year":"2009","unstructured":"Meinhardt J, Sachse C, Hortschansky P, Grigorieff N, Fandrich M. Abeta(1-40) fibril polymorphism implies diverse interaction patterns in amyloid fibrils. J Mol Biol. 2009;386:869\u201377.","journal-title":"J Mol Biol"},{"key":"3245_CR73","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1038\/s41594-020-0442-4","volume":"27","author":"C Roder","year":"2020","unstructured":"Roder C, Kupreichyk T, Gremer L, Schafer LU, Pothula KR, Ravelli RBG, et al. Cryo-EM structure of islet amyloid polypeptide fibrils reveals similarities with amyloid-beta fibrils. Nat Struct Mol Biol. 2020;27:660\u20137.","journal-title":"Nat Struct Mol Biol"},{"key":"3245_CR74","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1152\/physrev.00042.2009","volume":"91","author":"P Westermark","year":"2011","unstructured":"Westermark P, Andersson A, Westermark GT. Islet amyloid polypeptide, islet amyloid, and diabetes mellitus. Physiol Rev. 2011;91:795\u2013826.","journal-title":"Physiol Rev"},{"key":"3245_CR75","doi-asserted-by":"publisher","first-page":"8579","DOI":"10.1021\/acsnano.7b02325","volume":"11","author":"ST Wang","year":"2017","unstructured":"Wang ST, Lin Y, Spencer RK, Thomas MR, Nguyen AI, Amdursky N, et al. Sequence-dependent self-assembly and structural diversity of islet amyloid polypeptide-derived beta-sheet fibrils. ACS Nano. 2017;11:8579\u201389.","journal-title":"ACS Nano"},{"key":"3245_CR76","first-page":"35","volume":"146","author":"I Silva","year":"2025","unstructured":"Silva I, Silva MFD, Dutra TSA, Souza SO, Araujo-Junior JX, Leite ACR, et al. Alpha-synuclein aggregation in Parkinson\u2019s disease. Adv Protein Chem Struct Biol. 2025;146:35\u201375.","journal-title":"Adv Protein Chem Struct Biol"},{"key":"3245_CR77","doi-asserted-by":"publisher","first-page":"17963","DOI":"10.1073\/pnas.1906124116","volume":"116","author":"K Araki","year":"2019","unstructured":"Araki K, Yagi N, Aoyama K, Choong CJ, Hayakawa H, Fujimura H, et al. Parkinson\u2019s disease is a type of amyloidosis featuring accumulation of amyloid fibrils of alpha-synuclein. Proc Natl Acad Sci USA. 2019;116:17963\u20139.","journal-title":"Proc Natl Acad Sci USA"},{"key":"3245_CR78","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms3575","volume":"4","author":"L Bousset","year":"2013","unstructured":"Bousset L, Pieri L, Ruiz-Arlandis G, Gath J, Jensen PH, Habenstein B, et al. Structural and functional characterization of two alpha-synuclein strains. Nat Commun. 2013;4:2575.","journal-title":"Nat Commun"},{"key":"3245_CR79","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-05971-2","volume":"9","author":"B Li","year":"2018","unstructured":"Li B, Ge P, Murray KA, Sheth P, Zhang M, Nair G, et al. Cryo-EM of full-length alpha-synuclein reveals fibril polymorphs with a common structural kernel. Nat Commun. 2018;9:3609.","journal-title":"Nat Commun"},{"key":"3245_CR80","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-15472-4","volume":"12","author":"D Atarod","year":"2022","unstructured":"Atarod D, Mamashli F, Ghasemi A, Moosavi-Movahedi F, Pirhaghi M, Nedaei H, et al. Bivalent metal ions induce formation of alpha-synuclein fibril polymorphs with different cytotoxicities. Sci Rep. 2022;12:11898.","journal-title":"Sci Rep"},{"key":"3245_CR81","doi-asserted-by":"publisher","DOI":"10.1002\/agt2.333","volume":"4","author":"Q Xu","year":"2023","unstructured":"Xu Q, Ma Y, Sun Y, Li D, Zhang X, Liu C. Protein amyloid aggregate: structure and function. Aggregate. 2023;4:e333.","journal-title":"Aggregate"},{"key":"3245_CR82","doi-asserted-by":"publisher","first-page":"9805","DOI":"10.1021\/bi700455c","volume":"46","author":"Y Yoshiike","year":"2007","unstructured":"Yoshiike Y, Akagi T, Takashima A. Surface structure of amyloid-beta fibrils contributes to cytotoxicity. Biochemistry. 2007;46:9805\u201312.","journal-title":"Biochemistry"},{"key":"3245_CR83","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1096\/fj.11-189381","volume":"26","author":"M Bucciantini","year":"2012","unstructured":"Bucciantini M, Nosi D, Forzan M, Russo E, Calamai M, Pieri L, et al. Toxic effects of amyloid fibrils on cell membranes: the importance of ganglioside GM1. FASEB J. 2012;26:818\u201331.","journal-title":"FASEB J"},{"key":"3245_CR84","doi-asserted-by":"publisher","first-page":"2407","DOI":"10.1021\/acs.biochem.3c00010","volume":"62","author":"Z Faidon Brotzakis","year":"2023","unstructured":"Faidon Brotzakis Z, Lohr T, Truong S, Hoff S, Bonomi M, Vendruscolo M. Determination of the structure and dynamics of the fuzzy coat of an amyloid fibril of IAPP using cryo-electron microscopy. Biochemistry. 2023;62:2407\u201316.","journal-title":"Biochemistry"},{"key":"3245_CR85","doi-asserted-by":"publisher","first-page":"34272","DOI":"10.1074\/jbc.M109.049809","volume":"284","author":"WF Xue","year":"2009","unstructured":"Xue WF, Hellewell AL, Gosal WS, Homans SW, Hewitt EW, Radford SE. Fibril fragmentation enhances amyloid cytotoxicity. J Biol Chem. 2009;284:34272\u201382.","journal-title":"J Biol Chem"},{"key":"3245_CR86","doi-asserted-by":"publisher","first-page":"20","DOI":"10.4161\/pri.4.1.11378","volume":"4","author":"WF Xue","year":"2010","unstructured":"Xue WF, Hellewell AL, Hewitt EW, Radford SE. Fibril fragmentation in amyloid assembly and cytotoxicity: when size matters. Prion. 2010;4:20\u201325.","journal-title":"Prion"},{"key":"3245_CR87","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-21937-3","volume":"12","author":"R Cascella","year":"2021","unstructured":"Cascella R, Chen SW, Bigi A, Camino JD, Xu CK, Dobson CM, et al. The release of toxic oligomers from alpha-synuclein fibrils induces dysfunction in neuronal cells. Nat Commun. 2021;12:1814.","journal-title":"Nat Commun"},{"key":"3245_CR88","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1021\/acsnano.0c07555","volume":"15","author":"Z Ye","year":"2021","unstructured":"Ye Z, Geng X, Wei L, Li Z, Lin S, Xiao L. Length-dependent distinct cytotoxic effect of amyloid fibrils beyond optical diffraction limit revealed by nanoscopic imaging. ACS Nano. 2021;15:934\u201343.","journal-title":"ACS Nano"},{"key":"3245_CR89","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1021\/acschemneuro.9b00562","volume":"11","author":"X Zhang","year":"2020","unstructured":"Zhang X, Wesen E, Kumar R, Bernson D, Gallud A, Paul A, et al. Correlation between cellular uptake and cytotoxicity of fragmented alpha-synuclein amyloid fibrils suggests intracellular basis for toxicity. ACS Chem Neurosci. 2020;11:233\u201341.","journal-title":"ACS Chem Neurosci"},{"key":"3245_CR90","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-02056-4","volume":"8","author":"G Chen","year":"2017","unstructured":"Chen G, Abelein A, Nilsson HE, Leppert A, Andrade-Talavera Y, Tambaro S, et al. Bri2 BRICHOS client specificity and chaperone activity are governed by assembly state. Nat Commun. 2017;8:2081.","journal-title":"Nat Commun"},{"key":"3245_CR91","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1038\/nsmb.2971","volume":"22","author":"SIA Cohen","year":"2015","unstructured":"Cohen SIA, Arosio P, Presto J, Kurudenkandy FR, Biverstal H, Dolfe L, et al. A molecular chaperone breaks the catalytic cycle that generates toxic Abeta oligomers. Nat Struct Mol Biol. 2015;22:207\u201313.","journal-title":"Nat Struct Mol Biol"},{"key":"3245_CR92","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.ads7525","volume":"11","author":"Z Jin","year":"2025","unstructured":"Jin Z, Olsen WP, Morman C, Leppert A, Kumar R, Mollebjerg A, et al. Helicobacter pylori CagA protein is a potent and broad-spectrum amyloid inhibitor. Sci Adv. 2025;11:eads7525.","journal-title":"Sci Adv"},{"key":"3245_CR93","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1186\/s13024-021-00465-0","volume":"16","author":"MM Rahman","year":"2021","unstructured":"Rahman MM, Lendel C. Extracellular protein components of amyloid plaques and their roles in Alzheimer\u2019s disease pathology. Mol Neurodegener. 2021;16:59.","journal-title":"Mol Neurodegener"},{"key":"3245_CR94","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1186\/s40478-022-01356-1","volume":"10","author":"E Drummond","year":"2022","unstructured":"Drummond E, Kavanagh T, Pires G, Marta-Ariza M, Kanshin E, Nayak S, et al. The amyloid plaque proteome in early onset Alzheimer\u2019s disease and down syndrome. Acta Neuropathol Commun. 2022;10:53.","journal-title":"Acta Neuropathol Commun"},{"key":"3245_CR95","doi-asserted-by":"publisher","first-page":"3877","DOI":"10.4049\/jimmunol.181.6.3877","volume":"181","author":"M Yamamoto","year":"2008","unstructured":"Yamamoto M, Kiyota T, Walsh SM, Liu J, Kipnis J, Ikezu T. Cytokine-mediated inhibition of fibrillar amyloid-beta peptide degradation by human mononuclear phagocytes. J Immunol. 2008;181:3877\u201386.","journal-title":"J Immunol"},{"key":"3245_CR96","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1080\/13506129.2022.2155133","volume":"30","author":"JW Jackson","year":"2023","unstructured":"Jackson JW, Foster JS, Martin EB, Macy S, Wooliver C, Balachandran M, et al. Collagen inhibits phagocytosis of amyloid in vitro and in vivo and may act as a \u2018don\u2019t eat me\u2019 signal. Amyloid. 2023;30:249\u201360.","journal-title":"Amyloid"},{"key":"3245_CR97","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmb.2022.167919","volume":"435","author":"JA Buchanan","year":"2023","unstructured":"Buchanan JA, Varghese NR, Johnston CL, Sunde M. Functional amyloids: where supramolecular amyloid assembly controls biological activity or generates new functionality. J Mol Biol. 2023;435:167919.","journal-title":"J Mol Biol"},{"key":"3245_CR98","doi-asserted-by":"publisher","DOI":"10.1038\/srep44064","volume":"7","author":"JS Hee","year":"2017","unstructured":"Hee JS, Mitchell SM, Liu X, Leonhardt RM. Melanosomal formation of PMEL core amyloid is driven by aromatic residues. Sci Rep. 2017;7:44064.","journal-title":"Sci Rep"},{"key":"3245_CR99","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/j.cell.2012.06.019","volume":"150","author":"J Li","year":"2012","unstructured":"Li J, McQuade T, Siemer AB, Napetschnig J, Moriwaki K, Hsiao YS, et al. The RIP1\/RIP3 necrosome forms a functional amyloid signaling complex required for programmed necrosis. Cell. 2012;150:339\u201350.","journal-title":"Cell"},{"key":"3245_CR100","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-35854-0","volume":"14","author":"J Garcia-Pardo","year":"2023","unstructured":"Garcia-Pardo J, Bartolome-Nafria A, Chaves-Sanjuan A, Gil-Garcia M, Visentin C, Bolognesi M, et al. Cryo-EM structure of hnRNPDL-2 fibrils, a functional amyloid associated with limb-girdle muscular dystrophy D3. Nat Commun. 2023;14:239.","journal-title":"Nat Commun"},{"key":"3245_CR101","doi-asserted-by":"publisher","first-page":"3508","DOI":"10.1007\/s00259-022-05784-y","volume":"49","author":"HG Pemberton","year":"2022","unstructured":"Pemberton HG, Collij LE, Heeman F, Bollack A, Shekari M, Salvado G, et al. Quantification of amyloid PET for future clinical use: a state-of-the-art review. Eur J Nucl Med Mol Imaging. 2022;49:3508\u201328.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"3245_CR102","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.arr.2015.12.008","volume":"30","author":"I Tooyama","year":"2016","unstructured":"Tooyama I, Yanagisawa D, Taguchi H, Kato T, Hirao K, Shirai N, et al. Amyloid imaging using fluorine-19 magnetic resonance imaging ((19)F-MRI). Ageing Res Rev. 2016;30:85\u201394.","journal-title":"Ageing Res Rev"},{"key":"3245_CR103","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1038\/s41551-022-00906-1","volume":"6","author":"R Ni","year":"2022","unstructured":"Ni R, Chen Z, Dean-Ben XL, Voigt FF, Kirschenbaum D, Shi G, et al. Multiscale optical and optoacoustic imaging of amyloid-beta deposits in mice. Nat Biomed Eng. 2022;6:1031\u201344.","journal-title":"Nat Biomed Eng"},{"key":"3245_CR104","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1056\/NEJMoa2212948","volume":"388","author":"CH van Dyck","year":"2023","unstructured":"van Dyck CH, Swanson CJ, Aisen P, Bateman RJ, Chen C, Gee M, et al. Lecanemab in early Alzheimer\u2019s disease. N Engl J Med. 2023;388:9\u201321.","journal-title":"N Engl J Med"},{"key":"3245_CR105","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1001\/jamaneurol.2025.0065","volume":"82","author":"JA Zimmer","year":"2025","unstructured":"Zimmer JA, Ardayfio P, Wang H, Khanna R, Evans CD, Lu M, et al. Amyloid-Related imaging abnormalities with donanemab in early symptomatic alzheimer disease: secondary analysis of the TRAILBLAZER-ALZ and ALZ 2 Randomized Clinical Trials. JAMA Neurol. 2025;82:461\u20139.","journal-title":"JAMA Neurol"},{"key":"3245_CR106","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-43933-5","volume":"14","author":"E Solopova","year":"2023","unstructured":"Solopova E, Romero-Fernandez W, Harmsen H, Ventura-Antunes L, Wang E, Shostak A, et al. Fatal iatrogenic cerebral beta-amyloid-related arteritis in a woman treated with lecanemab for Alzheimer\u2019s disease. Nat Commun. 2023;14:8220.","journal-title":"Nat Commun"},{"key":"3245_CR107","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000209582","volume":"103","author":"J Neves Briard","year":"2024","unstructured":"Neves Briard J, Duquette A, Cayrol R, Lapalme-Remis S. Refractory status epilepticus in a patient with aducanumab-induced amyloid-related imaging abnormalities. Neurology. 2024;103:e209582.","journal-title":"Neurology"},{"key":"3245_CR108","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.pep.2011.11.004","volume":"82","author":"PN Datskevich","year":"2012","unstructured":"Datskevich PN, Mymrikov EV, Sluchanko NN, Shemetov AA, Sudnitsyna MV, Gusev NB. Expression, purification and some properties of fluorescent chimeras of human small heat shock proteins. Protein Expr Purif. 2012;82:45\u201354.","journal-title":"Protein Expr Purif"},{"key":"3245_CR109","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1007\/s12192-009-0151-8","volume":"15","author":"EV Mymrikov","year":"2010","unstructured":"Mymrikov EV, Bukach OV, Seit-Nebi AS, Gusev NB. The pivotal role of the beta 7 strand in the intersubunit contacts of different human small heat shock proteins. Cell Stress Chaperones. 2010;15:365\u201377.","journal-title":"Cell Stress Chaperones"},{"key":"3245_CR110","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1038\/227680a0","volume":"227","author":"UK Laemmli","year":"1970","unstructured":"Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970;227:680\u20135.","journal-title":"Nature"},{"key":"3245_CR111","doi-asserted-by":"publisher","first-page":"2158","DOI":"10.1021\/acs.analchem.3c05118","volume":"96","author":"MI Sulatsky","year":"2024","unstructured":"Sulatsky MI, Stepanenko OV, Stepanenko OV, Kuznetsova IM, Turoverov KK, Sulatskaya AI. Prediction of the feasibility of using the \u00abgold standard\u00bb thioflavin T to detect amyloid fibril in acidic media. Anal Chem. 2024;96:2158\u201364.","journal-title":"Anal Chem"},{"key":"3245_CR112","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.critrevonc.2008.02.008","volume":"68","author":"P Benes","year":"2008","unstructured":"Benes P, Vetvicka V, Fusek M. Cathepsin D\u2014many functions of one aspartic protease. Crit Rev Oncol Hematol. 2008;68:12\u201328.","journal-title":"Crit Rev Oncol Hematol"},{"key":"3245_CR113","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1111\/j.1432-1033.1982.tb06685.x","volume":"125","author":"A Hasilik","year":"1982","unstructured":"Hasilik A, von, Figura K, Conzelmann E, Nehrkorn H, Sandhoff K. Lysosomal enzyme precursors in human fibroblasts. Activation of cathepsin D precursor in vitro and activity of beta-hexosaminidase A precursor towards ganglioside GM2. Eur J Biochem. 1982;125:317\u201321.","journal-title":"Eur J Biochem"},{"key":"3245_CR114","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.1021\/bi00119a024","volume":"31","author":"GE Conner","year":"1992","unstructured":"Conner GE, Richo G. Isolation and characterization of a stable activation intermediate of the lysosomal aspartyl protease cathepsin D. Biochemistry. 1992;31:1142\u20137.","journal-title":"Biochemistry"},{"key":"3245_CR115","doi-asserted-by":"publisher","first-page":"21712","DOI":"10.1016\/S0021-9258(19)36670-0","volume":"267","author":"Y Okada","year":"1992","unstructured":"Okada Y, Gonoji Y, Naka K, Tomita K, Nakanishi I, Iwata K, et al. Matrix metalloproteinase 9 (92-kDa gelatinase\/type IV collagenase) from HT 1080 human fibrosarcoma cells. Purification and activation of the precursor and enzymic properties. J Biol Chem. 1992;267:21712\u20139.","journal-title":"J Biol Chem"},{"key":"3245_CR116","doi-asserted-by":"crossref","unstructured":"Stepanenko OV, Sulatsky MI, Mikhailova EV, Stepanenko OV, Povarova OI, Kuznetsova IM, et al. Alpha-B-crystallin effect on mature amyloid fibrils: different degradation mechanisms and changes in cytotoxicity. Int J Mol Sci. 2020;21:7659.","DOI":"10.3390\/ijms21207659"},{"key":"3245_CR117","unstructured":"Vladimirov YA, Litvin FF. Photobiology and spectroscopic methods. In: Handbook of general biophysics. Vol. 8. Moscow: High School; 1964. p. 88\u201391."},{"key":"3245_CR118","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-02237-7","volume":"7","author":"AI Sulatskaya","year":"2017","unstructured":"Sulatskaya AI, Lavysh AV, Maskevich AA, Kuznetsova IM, Turoverov KK. Thioflavin T fluoresces as excimer in highly concentrated aqueous solutions and as monomer being incorporated in amyloid fibrils. Sci Rep. 2017;7:2146.","journal-title":"Sci Rep"},{"key":"3245_CR119","doi-asserted-by":"publisher","first-page":"W315","DOI":"10.1093\/nar\/gky497","volume":"46","author":"A Micsonai","year":"2018","unstructured":"Micsonai A, Wien F, Bulyaki E, Kun J, Moussong E, Lee YH, et al. BeStSel: a web server for accurate protein secondary structure prediction and fold recognition from the circular dichroism spectra. Nucleic Acids Res. 2018;46:W315\u2013W322.","journal-title":"Nucleic Acids Res"},{"key":"3245_CR120","doi-asserted-by":"publisher","first-page":"W73","DOI":"10.1093\/nar\/gkaf378","volume":"53","author":"A Micsonai","year":"2025","unstructured":"Micsonai A, Wien F, Murvai N, Nyiri M\u00e1rtonP, Balatoni B, Lee Y-H, et al. BeStSel: analysis site for protein CD spectra\u20142025 update. Nucleic Acids Res. 2025;53:W73\u2013W83.","journal-title":"Nucleic Acids Res"},{"key":"3245_CR121","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1007\/s12035-012-8272-y","volume":"45","author":"IM Kuznetsova","year":"2012","unstructured":"Kuznetsova IM, Sulatskaya AI, Uversky VN, Turoverov KK. A new trend in the experimental methodology for the analysis of the thioflavin T binding to amyloid fibrils. Mol Neurobiol. 2012;45:488\u201398.","journal-title":"Mol Neurobiol"},{"key":"3245_CR122","doi-asserted-by":"publisher","first-page":"e30724","DOI":"10.1371\/journal.pone.0030724","volume":"7","author":"IM Kuznetsova","year":"2012","unstructured":"Kuznetsova IM, Sulatskaya AI, Uversky VN, Turoverov KK. Analyzing thioflavin T binding to amyloid fibrils by an equilibrium microdialysis-based technique. PLoS ONE. 2012;7:e30724.","journal-title":"PLoS ONE"},{"key":"3245_CR123","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1034\/j.1600-0773.2003.930104.x","volume":"93","author":"S Nishimura","year":"2003","unstructured":"Nishimura S, Murasugi T, Kubo T, Kaneko I, Meguro M, Marumoto S, et al. RS-4252 inhibits amyloid beta-induced cytotoxicity in HeLa cells. Pharmacol Toxicol. 2003;93:29\u201332.","journal-title":"Pharmacol Toxicol"},{"key":"3245_CR124","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/0022-1759(83)90303-4","volume":"65","author":"T Mosmann","year":"1983","unstructured":"Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J immunol Methods. 1983;65:55\u201363.","journal-title":"J immunol Methods"},{"key":"3245_CR125","doi-asserted-by":"crossref","unstructured":"Belousov MV, Kosolapova AO, Fayoud H, Sulatsky MI, Sulatskaya AI, Romanenko MN, et al. OmpC and OmpF outer membrane proteins of Escherichia coli and Salmonella enterica form bona fide amyloids. Int J Mol Sci. 2023;24:16568.","DOI":"10.3390\/ijms242115522"},{"key":"3245_CR126","unstructured":"Green MR, Sambrook J, Russell DW. Molecular cloning: a laboratory manual. 4th ed. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press; 2012."},{"key":"3245_CR127","doi-asserted-by":"publisher","first-page":"1760","DOI":"10.1073\/pnas.0813167106","volume":"106","author":"A Rath","year":"2009","unstructured":"Rath A, Glibowicka M, Nadeau VG, Chen G, Deber CM. Detergent binding explains anomalous SDS-PAGE migration of membrane proteins. Proc Natl Acad Sci USA. 2009;106:1760\u20135.","journal-title":"Proc Natl Acad Sci USA"},{"key":"3245_CR128","doi-asserted-by":"publisher","first-page":"14 11 11","DOI":"10.1002\/cpps.43","volume":"90","author":"I Braakman","year":"2017","unstructured":"Braakman I, Lamriben L, van Zadelhoff G, Hebert DN. Analysis of disulfide bond formation. Curr Protoc Protein Sci. 2017;90:14 11 11\u201314 11 21.","journal-title":"Curr Protoc Protein Sci"},{"key":"3245_CR129","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1110\/ps.062639307","volume":"16","author":"M Xu","year":"2007","unstructured":"Xu M, Shashilov VA, Ermolenkov VV, Fredriksen L, Zagorevski D, Lednev IK. The first step of hen egg white lysozyme fibrillation, irreversible partial unfolding, is a two-state transition. Protein Sci. 2007;16:815\u201332.","journal-title":"Protein Sci"}],"container-title":["Cell Death Discovery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41420-026-03245-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41420-026-03245-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41420-026-03245-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:03:16Z","timestamp":1790812996000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41420-026-03245-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,7]]},"references-count":129,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["3245"],"URL":"https:\/\/doi.org\/10.1038\/s41420-026-03245-1","relation":{},"ISSN":["2058-7716"],"issn-type":[{"value":"2058-7716","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,7]]},"assertion":[{"value":"2 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 June 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 June 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 July 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"The study did not involve human participants, primary patient-derived material, identifiable personal data, or animal subjects. Therefore, ethics approval and informed consent to participate were not required.","order":2,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"390"}}